FDA Adverse Event Injury Summary report: N

XIENCE V EVEROLIMUS ELUTING CORONARY STENT SYSTEM

MDR report key: 1920290 · Received December 10, 2010

Report

Report Number
2024168-2010-02666
Event Type
Injury
Date Received
December 10, 2010
Date of Event
January 26, 2010
Report Date
February 26, 2010
Manufacturer
AV-TEMECULA
Product Code
NIQ
PMA / PMN Number
P070015
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
AR, US
Reporter Occupation
HEALTH PROFESSIONAL

Narratives

Additional Manufacturer Narrative · 1

(B)(4). THERE WAS NO REPORTED PRODUCT DEFICIENCY. THE REPORTED ANGINA AND RE-STENOSIS ARE LISTED IN THE XIENCE V INSTRUCTIONS FOR USE AS KNOWN ADVERSE EVENTS ASSOCIATED WITH CORONARY STENTING AND ARE NOT NECESSARILY AN INDICATION OF A PRODUCT QUALITY DEFICIENCY. ALTHOUGH A CONCLUSIVE CAUSE FOR THE REPORTED PATIENT EFFECTS, AND THE RELATIONSHIP TO THE PRODUCT, IF ANY, CANNOT BE DETERMINED, THERE IS NO INDICATION OF A PRODUCT QUALITY DEFICIENCY WITH RESPECT TO MANUFACTURING, DESIGN OR LABELING.

Description of Event or Problem · 1

IT WAS REPORTED VIA A TRIAL THAT ON (B)(6) 2009 THAT THE PATIENT UNDERWENT STENTING IN THE FIRST DIAGONAL ARTERY WITH ONE 2.25 X 18 XIENCE V STENT. ON (B)(6) 2010, THE PATIENT EXPERIENCED CHEST PAIN AND WAS FOUND TO HAVE A LESION IN THE MID LEFT ANTERIOR DESCENDING (LAD) ARTERY AND A NEW LESION PROXIMAL TO THE STUDY STENT IN THE DIAGONAL. THE PATIENT UNDERWENT PERCUTANEOUS CORONARY REVASCULARIZATION ON (B)(6) 2010. THE PATIENT'S CONDITION RESOLVED ON (B)(6) 2010. THIS EVENT WAS ADJUDICATED BY THE CLINICAL EVENTS COMMITTEE AS A TARGET LESION REVASCULARIZATION FOR IN-STENT RESTENOSIS IN THE FIRST DIAGONAL AND A NON-TARGET LESION IN THE MID LAD. THERE WAS NO ADDITIONAL INFORMATION PROVIDED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 XIENCE V EVEROLIMUS ELUTING CORONARY STENT SYSTEM DRUG ELUTING CORONARY STENT SYSTEM NIQ AV-TEMECULA 90217P5

Patients

Seq Age Sex Outcome Treatment
1 77 YR Hospitalization| R